# IVEA: an integrative variational Bayesian inference method for predicting enhancer–gene regulatory interactions

**Authors:** Yasumasa Kimura, Yoshimasa Ono, Kotoe Katayama, Seiya Imoto

PMC · DOI: 10.1093/bioadv/vbae118 · Bioinformatics Advances · 2024-08-20

## TL;DR

IVEA is a new computational method that predicts how enhancers regulate genes using transcription data and chromatin features.

## Contribution

IVEA introduces a variational Bayesian inference framework based on transcriptional bursting to infer enhancer–gene interactions.

## Key findings

- IVEA achieves high accuracy in predicting enhancer–gene regulatory relationships.
- The method provides biologically relevant insights into enhancer–gene interactions.

## Abstract

Enhancers play critical roles in cell-type-specific transcriptional control. Despite the identification of thousands of candidate enhancers, unravelling their regulatory relationships with their target genes remains challenging. Therefore, computational approaches are needed to accurately infer enhancer–gene regulatory relationships.

In this study, we propose a new method, IVEA, that predicts enhancer–gene regulatory interactions by estimating promoter and enhancer activities. Its statistical model is based on the gene regulatory mechanism of transcriptional bursting, which is characterized by burst size and frequency controlled by promoters and enhancers, respectively. Using transcriptional readouts, chromatin accessibility, and chromatin contact data as inputs, promoter and enhancer activities were estimated using variational Bayesian inference, and the contribution of each enhancer–promoter pair to target gene transcription was calculated. Our analysis demonstrates that the proposed method can achieve high prediction accuracy and provide biologically relevant enhancer–gene regulatory interactions.

The IVEA code is available on GitHub at https://github.com/yasumasak/ivea. The publicly available datasets used in this study are described in Supplementary Table S4.

## Full-text entities

- **Genes:** TAF1 (TATA-box binding protein associated factor 1) [NCBI Gene 6872] {aka BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}, TBP (TATA-box binding protein) [NCBI Gene 6908] {aka GTF2D, GTF2D1, HDL4, SCA17, TBP1, TFIID}, GATA1 (GATA binding protein 1) [NCBI Gene 2623] {aka CNSHA9, ERYF1, GATA-1, GF-1, GF1, HAEADA}, ELK4 (ETS transcription factor ELK4) [NCBI Gene 2005] {aka SAP1}, SMIM1 (small integral membrane protein 1 (Vel blood group)) [NCBI Gene 388588] {aka Vel}, GATA2 (GATA binding protein 2) [NCBI Gene 2624] {aka DCML, IMD21, MONOMAC, NFE1B}, ELK1 (ETS transcription factor ELK1) [NCBI Gene 2002], PVT1 (Pvt1 oncogene) [NCBI Gene 5820] {aka LINC00079, MIR1204HG, NCRNA00079, TP53LC09, onco-lncRNA-100}, CTCF (CCCTC-binding factor) [NCBI Gene 10664] {aka CFAP108, FAP108, MRD21}, ABCB6 (ATP binding cassette subfamily B member 6 (LAN blood group)) [NCBI Gene 10058] {aka ABC, LAN, MTABC3, PRP, umat}, ETV1 (ETS variant transcription factor 1) [NCBI Gene 2115] {aka ER81}, FUT1 (fucosyltransferase 1 (H blood group)) [NCBI Gene 2523] {aka H, HH, HSC}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}
- **Diseases:** Autoimmune disease (MESH:D001327)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs137
- **Cell lines:** GM12878 — Homo sapiens (Human), Transformed cell line (CVCL_7526), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), LCLs — Homo sapiens (Human), Transformed cell line (CVCL_C0HY), Hi — Trichoplusia ni (Cabbage looper), Spontaneously immortalized cell line (CVCL_C190), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11349192/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11349192/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC11349192/full.md

---
Source: https://tomesphere.com/paper/PMC11349192